XML 46 R45.htm IDEA: XBRL DOCUMENT v3.20.1
Note 17 - Stock-based Compensation Plans (Tables)
12 Months Ended
Jan. 31, 2020
Notes Tables  
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Year Ended    
January 31,
     
January 31,
     
January 31,
 
      2020       2019       2018  
Cost of revenues    
220
     
160
     
90
 
Sales and marketing    
706
     
436
     
246
 
Research and development    
281
     
184
     
85
 
General and administrative    
3,702
     
2,930
     
2,386
 
Effect on net income    
4,909
     
3,710
     
2,807
 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Year Ended    
January 31, 2020
     
January 31, 2019
     
January 31, 2018
 
  Expected dividend yield (%)    
     
     
 
  Expected volatility (%)    
23.5
     
23.6
     
23.5
 
  Risk-free rate (%)    
1.4
     
2.0
     
1.0
 
  Expected option life (years)    
5
     
5
     
5
 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
     
Number of Stock Options Outstanding
     
Weighted-
Average Exercise
Price
     
Weighted- Average Remaining Contractual Life (years)
     
Aggregate Intrinsic
Value
(in millions)
 
Balance at January 31, 2018    
657,209
    $
18.21
     
4.9
     
5.7
 
Granted    
272,144
    $
27.96
     
 
     
 
 
Exercised    
(46,065
)   $
11.75
     
 
     
 
 
Forfeited    
(3,950
)   $
26.43
     
 
     
 
 
Balance at January 31, 2019    
879,338
    $
21.41
     
4.7
     
8.7
 
Granted    
367,173
    $
38.06
     
 
     
 
 
Exercised    
(94,970
)   $
15.62
     
 
     
 
 
Forfeited    
(23,719
)   $
31.93
     
 
     
 
 
Balance at January 31, 2020    
1,127,822
    $
26.82
     
4.6
     
20.2
 
                                 
Vested or expected to vest at January 31, 2020    
1,127,822
    $
26.82
     
4.6
     
20.2
 
                                 
Exercisable at January 31, 2020    
718,169
    $
22.88
     
4.0
     
15.7
 
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
    Options Outstanding   Options Exercisable
Range of Exercise Prices    
Weighted
Average Exercise Price
     
Number of Stock Options
     
Weighted Average Remaining Contractual Life (years)
     
Weighted Average Exercise Price
     
Number of Stock Options
 
$11.43 – $11.59
 
$
11.57
     
126,500
     
1.4
    $
11.57
     
126,500
 
$18.71 – $22.57
 
$
21.17
     
397,014
     
3.8
    $
21.08
     
357,014
 
$25.91 – $27.50
 
$
27.49
     
247,935
     
5.2
    $
27.49
     
140,461
 
$38.04 – $39.70
 
$
38.07
     
356,373
     
6.2
    $
38.06
     
94,194
 
 
 
$
26.82
     
1,127,822
     
4.6
    $
22.88
     
718,169
 
Schedule of Nonvested Share Activity [Table Text Block]
     
Number of Stock Options Outstanding
     
Weighted-Average Grant-Date Fair Value per Share
 
Balance at January 31, 2018    
276,067
    $
4.98
 
Granted    
272,144
    $
7.10
 
Vested    
(219,043
)   $
5.56
 
Forfeited    
(3,950
)   $
6.41
 
Balance at January 31, 2019    
325,218
    $
6.18
 
Granted    
367,173
    $
8.99
 
Vested    
(259,269
)   $
6.96
 
Forfeited    
(23,469
)   $
7.69
 
Balance at January 31, 2020    
409,653
    $
8.03
 
Share-based Payment Arrangement, Performance Shares, Outstanding Activity [Table Text Block]
     
Number of PSUs Outstanding
     
Weighted-
Average Granted Date Fair Value
     
Weighted- Average Remaining Contractual Life (years)
     
Aggregate Intrinsic
Value
(in millions)
 
Balance at January 31, 2018    
440,520
    $
15.91
     
6.1
     
11.9
 
Granted    
54,351
    $
35.23
     
 
     
 
 
Performance units issued    
35,512
    $
19.59
     
 
     
 
 
Balance at January 31, 2019    
530,383
    $
18.02
     
5.5
     
16.6
 
Granted    
53,729
    $
53.65
     
 
     
 
 
Performance units issued    
45,762
    $
23.24
     
 
     
 
 
Balance at January 31, 2020    
629,874
    $
21.19
     
5.0
     
28.2
 
                                 
Vested or expected to vest at January 31, 2020    
629,874
    $
21.19
     
5.0
     
28.2
 
                                 
Exercisable at January 31, 2020    
521,794
    $
16.45
     
4.3
     
23.4
 
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
     
Number of RSUs Outstanding
     
Weighted-
Average Granted Date Fair Value
     
Weighted- Average Remaining Contractual Life (years)
     
Aggregate Intrinsic
Value
(in millions)
 
Balance at January 31, 2018    
299,020
    $
12.80
     
6.1
     
8.1
 
Granted    
38,046
    $
27.96
     
 
     
 
 
Balance at January 31, 2019    
337,066
    $
14.42
     
5.6
     
10.6
 
Granted    
37,611
    $
38.04
     
 
     
 
 
Balance at January 31, 2020    
374,677
    $
16.57
     
5.0
     
16.8
 
                                 
Vested or expected to vest at January 31, 2020    
374,677
    $
16.57
     
5.0
     
16.8
 
                                 
Exercisable at January 31, 2020    
336,921
    $
14.56
     
4.6
     
15.1
 
Schedule Of Cash Settled Restricted Share Unit Plan Activity [Table Text Block]
     
Number of CRSUs Outstanding
     
Weighted- Average Remaining Contractual Life (years)
 
Balance at January 31, 2018    
58,171
     
1.5
 
Granted    
32,261
     
 
 
Vested and settled in cash    
(45,369
)    
 
 
Balance at January 31, 2019    
45,063
     
1.6
 
Granted    
30,086
     
 
 
Vested and settled in cash    
(32,422
)    
 
 
Balance at January 31, 2020    
42,727
     
1.6
 
                 
Non-vested at January 31, 2020    
42,727
     
1.6